We suggest that during the premalignant stage of OSCC development, namely, OPMD, putative cancer cells become progressively immortalised by the inactivation of both TP53 and CDKN2A and the activation of telomerase. This evidence concerns the gene TP53 and oculopharyngeal muscular dystrophy.